Article 05 Jul 2022 PMPRB Update: Proposed Interim PMPRB Guidelines -- The "Status Quo" Canada Healthcare
Article 11 May 2022 New Medicines Landscape In Canada & Abroad: PMPRB Outlines Trends In Pharmaceutical Approvals, Sales And Drug Pricing Canada Healthcare
Article 27 Apr 2022 PMPRB To Issue "New And Different" Guidelines In Light Of Health Canada's Decision Not To Proceed With Proposed Amendments Found Unconstitutional Canada Healthcare
Article 19 Apr 2022 PMPRB Update: Canadian Government Announces It Will No Longer Seek To Implement Price Regulatory Factors Or Requirement To Report Net Prices Canada Healthcare
Article 12 Apr 2022 PMPRB Update: PMPRB Is Accepting Intervener Leave Applications For SOLIRIS Re-hearing Canada IP
Article 29 Mar 2022 PMPRB Update: Supreme Court Refuses To Hear Appeal From Decision Restricting Canada's Patented Medicine Pricing Review Board's Drug Price Mandate Canada IP
Article 01 Mar 2022 PMPRB Update: Major Aspects Of Proposed Amendments Found Unconstitutional Canada IP
Article 06 Nov 2020 2020 Brings Growing Trend Of Patent Cases Decided By Way Of Summary Trial Canada IP
Article 05 May 2020 First Trial Decision Under Canada's Amended Patented Medicines (Notice Of Compliance) Regulations Offers Guidance On Key Issues Canada IP
Article 23 Aug 2019 Federal Government Publishes Amendments Significantly Altering Canada's Patented Medicines Pricing Regime Canada IP
Article 14 Aug 2019 Overhaul Of Canadian Pharmaceutical Pricing Regulations: Amendments To Be Published August 21, 2019 Canada Healthcare
Article 12 Jul 2019 Federal Court Of Appeal Provides Important Guidance For Determining Jurisdiction Of The PMPRB Canada IP
Article 15 Oct 2018 Post-AstraZeneca: Has The Promise Doctrine Vanished From Patent Litigation? Likely, Yes Canada IP